Nowadays, pharmaceutical launches are becoming harder and more competitive. In some cases, MSD products are neither the only nor the first player in the market. Besides, clinical data can be comparable with the products of other laboratories. 
InnoStars is recruiting participants for its fellowship program (StarShip) from InnoStars countries and other RIS eligible countries outside EIT Health. StarShip is an EIT Health educational initiative in collaboration with leading European health industrial partners - lead by the University of Coimbra and IESE Business School and the Royal Institute of Technology (KTH). 
CUBE, a global ecosystem dedicated to connecting startups and corporations, opened its new collaboration space in Berlin. The space is the official point of connection between CUBE's curated startups and its partners. CUBE aims to facilitate even greater connections between industry leaders and innovative B2B startups by placing teams side by side. 
Novartis has announced the launch of an innovative technology-based healthcare program called SMS for Life 2.0 in Kaduna State, Nigeria. The program aims to increase the availability of essential medicines and improve care for patients across the region by using simple, available, and affordable technology. 
Giving people with disabilities the power to control objects with their minds, automating breast health monitoring and a wireless injectable device for connected drug delivery services are among the innovative technologies being developed by the eight semifinalists selected for the Accenture HealthTech Innovation Challenge. 
IBM (NYSE: IBM) Watson Health and Pfizer Inc. (NYSE: PFE) have announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer's research in immuno-oncology, an approach to cancer treatment that uses the body's immune system to help fight cancer. 
Nuritas, the Irish digital-biotechnology and R&D company founded by Dr Nora Khaldi, has announced it will triple its workforce in Ireland to over 60 in 2017 as part of a major expansion of its Irish operations. It has also confirmed U2 band members Bono and The Edge as investors in the company.